Science
Cancun: Moon Palace Trumps Planet Earth
Prabir Purkayastha, December 12th, 2010
GM Foods and Bt Brinjal: Interview with Prof. Rich Jefferson, Cambia
Newsclick/ May 8, 2010
Satyajit Rath, scientist at the National Institute of Immunology, New Delhi interviews Dr. Richard Jefferson, eminent molecular biologist and the founder of "Open Source Biology" that is changing the paradigm of practising science.
The Lunacy of Gene Patenting & Angelina Jolie's Mastectomy
Prabir Purkayastha, May 16, 2013
Angelina Jolie's Op-Ed piece in the New York Times (May 14, 2013) stating why she had a double mastectomy (or breast removal) has created a media sensation across the world.
Clinical Trials in India: Brazen Cocktail of Corporate Crimes, Corrupt Government and Exploitation of the Poor
Newsclick Production, May 07, 2013
The Parliamentary Committee report on health tabled in the Parliament last month shockingly exposes the reckless attitude and the complicity of the Health Ministry, Drug Controller General of India's office and the Central Drug Standard Control Organisation in helping Multinational pharmaceutical companies in conducting clinical trials on poor patients in India leading to 2644 deaths during clinical trials since 2005. Neha Dixit interviews Amulya Nidhi, co-convenor of Swasthya Adhikar Manch, the organisation that filed the much needed petition on Clinical trials in the Supreme Court of India which opened a pandora's box on the issue and helped hold the Union of India accountable.
Novartis Case, Innovation and Patents
"The Patent System Puts Brakes on Innovation rather than Promoting it."
Newsclick Production, April 13, 2013
Newsclick discusses with Dr. Amit Sengupta the impact of the recent Supreme Court judgement in the Novartis case on the Indian pharmaceutical sector, the Public Health Policy in the country and the R&D policies of foreign pharmaceutical manufacturers.
Gorakhpur Nuclear Power Plant: A Flawed Proposal
Newsclick Production, April 6, 2013
Newsclick discusses with D Raghunandan the repurcussions of the proposed Nuclear Power Plant at Gorakhpur in Haryana. There are many problems with this proposed plant, specially relating to siting and sources of water. The only possible source of water for the NPP is the Bhakra canal. Apart from this, the site has a high density of population around. Raghunandan feels there is a political commitment to go ahead with nuclear technology, regardless of costs. He says all sources of energy should be evaluated dispassionately, clearly taking into account the costs, risks, potential benefits, and then the more suitable one should be opted. He thinks such an analysis would put nuclear energy at the bottom of this.
Baby 'cured' of HIV: A breakthrough with limitations
Newsclick Production, March 14, 2013
The news from Mississippi of an HIV-positive baby being 'cured' has once again started discussions around the plausibility of a breakthrough. Dr. Satyajit Rath discusses with Newsclick the reasons which are possibly behind what is termed as 'functionally cured.' He suggests that treating infection early on when the baby is exposed to it is almost like prevention. But since there is no accurate way of knowing when an adult is exposed to HIV, can the approach used in the baby's case be of any significance to the adult community infected with HIV?
India's Poor are Rich Pharma's Guinea Pigs
Sana Amir, Salma Rehman and Zainab Sayeed (Students of AJK MCRC, Jamia Milia Islamia University), February 27, 2013
Newsclick hosts selected news features of students from AJK MCRC, Jamia Milia Islamia University. Over 2000 people have died during clinical drug trials in the last four years in India but only 22 have been compensated. A report by Sana Amir, Salma Rehman and Zainab Sayeed.
Disclaimer: The views expressed here are the author's personal views, and do not necessarily represent the views of Newsclick
Recounting the Personal Experiences in Accessing Herceptin
Newsclick Production, February 27, 2013
In this Newsclick interview, Kalyani Menon, Co-ordinator of the Campaign for Affordable Trastuzumab (Herceptin) speaks to Ravish Mehra, husband of a breast cancer survivor who recounts his experiences in accessing Herceptin, and the travails faced therein.


